• 01.01.14

    Mary S. Young Elevated to Blackwell Burke P.A. Partnership

    Blackwell Burke P.A. is pleased to announce that attorney Mary S. Young has been elevated to the firm’s partnership. Ms. Young joined the firm in 2011. She is an experienced trial lawyer whose practice is focused on commercial and products liability litigation. She is well-versed in all aspects of civil trial and pre-trial practice including the handling of complex cases, arbitrations, and the defense of consumer class actions. Ms. Young is admitted to practice in Minnesota and Washington State. Ms. Young is the founder and president of the Minnesota Mother Attorneys Association (MMAA). MMAA is a legal organization dedicated to…
  • 12.13.13

    Blackwell Burke P.A. Receives Excellence in Service Award from General Mills, Inc.

    Blackwell Burke P.A. was honored to receive the Excellence in Service Award from General Mills, Inc.  The honor recognizes the firm’s “outstanding partnership and service” to General Mills’ legal department.  General Mills Chief Litigation Counsel Ani Gulati explained, “The law firm of Blackwell Burke P.A. has worked on some of our most significant litigation in the last year.  They have provided exemplary service and obtained excellent results.” Award presenter and General Mills Finance Director Darren Harmon described Blackwell Burke P.A.’s accomplishments in the past year including working as lead counsel for the company on their YoPlus class action and the…
  • 11.22.13

    Peter J. Goss Shares Insights on Johnson & Johnson Hip Settlement

    Blackwell Burke P.A. partner Peter J. Goss commented for two Law360 articles analyzing Johnson & Johnson’s landmark $2.5 billion ASR hip settlement.   In the first article, Goss discusses considerations for evaluating claims excluded from the settlement, and in the second, he praises the settlement’s game-changing approach to the resolution of payer and provider liens.  The articles are available to Law360 subscribers here and here. Mr. Goss focuses his national practice on pharmaceutical and medical device product liability litigation and toxic torts. He has represented major pharmaceutical, medical technology, and chemical firms in hundreds of cases. Mr. Goss, who has won several published Daubert decisions, often…
  • 11.01.13

    Benchmark Litigation Recommends Blackwell Burke P.A. and Selects Four Attorneys as Litigation Stars

    Benchmark Litigation, an independent guide to leading litigation firms and attorneys nationwide, has included Blackwell Burke P.A. as a recommended firm in its 2014 Minnesota listing.  Recommended firms are those that are consistently acknowledged by clients and competitors during Benchmark Litigation’s six-month research process.  Jerry W. Blackwell, Mike Hatch, and Peter J. Goss were each honored as Minnesota litigation stars.  Litigation star designation is based on competitors and clients recommending these attorneys as “reputable and effective litigators” during Benchmark Litigation’s independent interviews.  Benjamin W. Hulse was named a future Minnesota litigation star.  Future stars are young partners who are predicted…
  • 10.23.13

    Brendan M. Kenny Discusses the Use of RICO Suits to Address Fraudulent Litigation in Law360

    Law360 interviewed Blackwell Burke P.A. attorney Brendan M. Kenny for a recent article discussing the use of the Racketeer Influenced and Corrupt Organizations Act (RICO) to punish litigation fraud.  The article was about the American Tort Reform Association's call on companies to wield RICO as a weapon against plaintiffs attorneys who bring fraudulent litigation.  Mr. Kenny discussed the challenges that companies face when bringing RICO lawsuits.  Mr. Kenny explained that companies bringing RICO suits risk becoming targets of other plaintiffs' lawyers and losing credibility with the court if the suit is ultimately unsuccessful.  The full article is available to Law360…
  • 10.15.13

    Peter J. Goss Discusses Maine Drug Importation Law in Law360

    Law360 interviewed Blackwell Burke P.A. partner Peter J. Goss on the potential unintended consequences of a recently enacted Maine law that allows state residents to purchase prescription drugs from online pharmacies based outside the U.S.  Goss noted that consumers experiencing adverse reactions will have difficulty pursuing foreign pharmacies and drug manufacturers in U.S. Courts. The full article is available to Law360 subscribers here. Mr. Goss focuses his national practice on pharmaceutical and medical device product liability litigation and toxic torts. He has represented major pharmaceutical, medical technology, and chemical firms in hundreds of cases. Mr. Goss, who has won several published Daubert decisions, often serves as…

Interested in learning more?

Email Disclaimer Close

Sending us an email will not make you a client of our firm. Until we have agreed to represent you, nothing you send us will be confidential or privileged.

If your email is related to representation, the best way for you to inquire about a possible representation is to call a Blackwell Burke P.A. attorney at one of the telephone numbers listed on our Attorney's page. An attorney will first take you through our conflict of interest procedure and see that you are put in touch with the lawyer best suited to handle your matter.

If you proceed with an email, you confirm that you have read and understand this notice. To proceed, click I Agree.